Literature DB >> 12947003

Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model.

Françoise Norol1, Pascal Merlet, Richard Isnard, Pascale Sebillon, Nicolas Bonnet, Christian Cailliot, Claire Carrion, Maria Ribeiro, Frédéric Charlotte, Pascal Pradeau, Jean-François Mayol, André Peinnequin, Michel Drouet, Karima Safsafi, Jean-Paul Vernant, Francis Herodin.   

Abstract

Although previous findings have suggested that some adult stem cells are pluripotent and could differentiate in an appropriate microenvironment, the fate conversion of adult stem cells is currently being debated. Here, we studied the ability of mobilized stem cells to repair cardiac tissue injury in a nonhuman primate model of acute myocardial infarction. Mobilization was carried out with stem cell factor, 25 mcg/Kg/d (D), and granulocyte-colony-stimulating factor, 100 mcg/Kg/D administered 5 days before (D - 5 group; n = 3) or 4 hours after (H + 4 group; n = 4) circumflex coronary artery ligation; no growth factor was administered to 3 baboons of the control group. No adverse effect relating to growth factor administration was observed. Flk-1 and transcription factors of cardiac lineages could be detected in peripheral blood only by reverse transcriptase-polymerase chain reaction. When comparing positron emission tomography (PET) with [11C]-acetate between examinations from D2 and D30, a relative increase (perfusion ratio between infarct and noninfarct regions) of 26% (P =.01) in myocardial blood flow was found in the H + 4 group; the relative rate of oxidative metabolism remained unaltered in the 3 groups. No change was observed in the echographic indices of the left ventricular enlargement or systolic function in the 3 animal groups during the 2-month follow-up. The PET findings concurred with the immunohistochemistry analysis of left ventricular myocardial sections with evidence of endothelial cells but no myocyte differentiation; few cycling cells were observed at this time. Thus, the present data suggest that, in nonhuman primates submitted to coronary artery ligation, mobilization by hematopoietic growth factors could promote angiogenesis in the infarcted myocardium, without detectable myocardial repair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12947003     DOI: 10.1182/blood-2003-03-0685

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  The role of stem cells in cardiac regeneration.

Authors:  Anke M Smits; Patrick van Vliet; Rutger J Hassink; Marie-José Goumans; Pieter A Doevendans
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

2.  Multipotent stem cells in cardiac regenerative therapy.

Authors:  Ravi Karra; Sean M Wu
Journal:  Regen Med       Date:  2008-03       Impact factor: 3.806

Review 3.  Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction.

Authors:  Hiroyuki Takano; Yingjie Qin; Hiroshi Hasegawa; Kazutaka Ueda; Yuriko Niitsuma; Masashi Ohtsuka; Issei Komuro
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

Review 4.  Cardiac repair--fact or fancy?

Authors:  E Leontiadis; A Manginas; D V Cokkinos
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

5.  Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice.

Authors:  Agung Purnama; Rachida Aid-Launais; Oualid Haddad; Muriel Maire; Diego Mantovani; Didier Letourneur; Hanna Hlawaty; Catherine Le Visage
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 6.  Myocardial remodeling: cellular and extracellular events and targets.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

7.  Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury.

Authors:  Luis F Miranda; Claudia O Rodrigues; Shalini Ramachandran; Eneida Torres; Jian Huang; Jammie Klim; Dorothy Hehre; Ian McNiece; Joshua M Hare; Cleide Y Suguihara; Karen C Young
Journal:  Pediatr Res       Date:  2013-10-23       Impact factor: 3.756

8.  Stem cells for heart cell therapies.

Authors:  Donghui Jing; Abhirath Parikh; John M Canty; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part B Rev       Date:  2008-12       Impact factor: 6.389

9.  Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.

Authors:  Rutger J Hassink; Kishore B Pasumarthi; Hidehiro Nakajima; Michael Rubart; Mark H Soonpaa; Aart Brutel de la Rivière; Pieter A Doevendans; Loren J Field
Journal:  Cardiovasc Res       Date:  2007-12-12       Impact factor: 10.787

10.  Analysis of progenitor cell mobilization and erythropoietin plasma levels in patients with acute myocardial infarction.

Authors:  Korff Krause; Boris Fehse; Kai Jaquet; Claudia Lange; Konstantin Kyriazis; Sigrid Boczor; Axel Zander; Karl-Heinz Kuck
Journal:  Exp Clin Cardiol       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.